Status:
RECRUITING
Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program
Lead Sponsor:
Dasman Diabetes Institute
Conditions:
Diabetes Mellitus Type 2, Diabetes Mellitus Type 1
NAFLD - Nonalcoholic Fatty Liver Disease
Eligibility:
All Genders
21-75 years
Brief Summary
Kuwait and the Gulf Region lack large longitudinal studies that identify risk factors dictating the onset of prediabetes and the progression to diabetes. The Kuwait Diabetes Epidemiology Program (KDEP...
Detailed Description
The rapid increase of obesity and the detrimental complications associated with it, particularly insulin resistance, Type 2 diabetes (T2D), hypertension and cardiovascular disorders, represent a major...
Eligibility Criteria
Inclusion
- People who participated in the original KDEP study. People with prediabetes. Type 2 Diabetes patients.
Exclusion
- People are unwilling to sign the consent form. Pregnant women.
Key Trial Info
Start Date :
May 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 23 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06115876
Start Date
May 23 2022
End Date
May 23 2027
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dasman Diabetes Institute
Kuwait City, Kuwait, 40000